Maternal exposure to secondhand cigarette smoke primes the lung for induction of phosphodiesterase-4D5 isozyme and exacerbated Th2 responses: Rolipram attenuates the airway hyperreactivity and muscarinic receptor expression but not lung inflammation and atopy

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 2115-2121

  Singh, Shashi P ^a   Mishra, Neerad C ^a   Rir sima ah, Jules ^a   Campen, Mathew ^a   Kurup, Viswanath ^b   Razani Boroujerdi, Seddigheh ^a   Sopori, Mohan L ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; PHOSPHODIESTERASE IV; ROLIPRAM; CYTOKINE; ISOENZYME;

AIRWAY RESISTANCE; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; FETUS; INFLAMMATION; LUNG; MALE; MOUSE; NONHUMAN; PASSIVE SMOKING; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; TH2 CELL; UPREGULATION; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; PNEUMONIA; PREGNANCY;

AIRWAY RESISTANCE; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYTOKINES; FEMALE; HUMANS; ISOENZYMES; MATERNAL EXPOSURE; MICE; PNEUMONIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, MUSCARINIC; ROLIPRAM; TH2 CELLS; TOBACCO SMOKE POLLUTION;

EID: 68149180520     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900826     Document Type: Article

References (61)

1. Sopori, M. 2002. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2: 372-377. (Pubitemid 37328760)
2. DiFranza, J. F., A. Aligne, and M. Weitzman. 2004. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 113: 1007-1015. (Pubitemid 38437353)
3. Bradley, J. P., L. B. Bacharier, J. Bonfiglio, K. B. Schechtman, R. Strunk, G. Storch, and M. Castro. 2005. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115: e7-e14.
4. Environmental Protection Agency. 1992. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. US EPA Office Research and Development, Washington, D.C.
5. Cliver, S. P., R. L. Goldenberg, G. R. Cutter, H. J. Hoffman, R. O. Davis, and K. G. Nelson. 1995. The effect of cigarette smoking on neonatal anthropometric measurements. Obstet. Gynecol. 85: 625-630.
6. Wen, S. W., R. L. Goldenberg, G. R. Cutter, H. J. Hoffman, S. P. Cliver, R. O. Davis, and M. B. DuBard. 1990. Smoking, maternal age, fetal growth, and gestational age at delivery. Am. J. Obstet. Gynecol. 162: 53-58.
7. Taylor, B., and J. Wadsworth. 1987. Maternal smoking during pregnancy and lower respiratory tract illness in early life. Arch. Dis. Child. 62: 786-791. (Pubitemid 17128825)
8. Sekhon, H. S., B. J. Proskocil, J. A. Clark, and E. R. Spindel. 2004. Prenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels. Eur. Respir. J. 23: 906-915.
9. Tager, I. B., J. P. Hanrahan, T. D. Tosteson, R. G. Castile, R. W. Brown, S. T. Weiss, and F. E. Speizer. 1993. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am. Rev. Respir. Dis. 147: 811-817.
10. Cunningham, J., D. W. Dockery, and F. E. Speizer. 1994. Maternal smoking during pregnancy as a predictor of lung function in children. Am. J. Epidemiol. 139: 1139-1152. (Pubitemid 24184408)
11. Mathews, T. J. 2001. Smoking during pregnancy in the 1990s. Natl. Vital Stat. Rep. 49: 1-14.
12. Singh, S. P., S. Razani-Boroujerdi, J. C. Peña-Philippides, R. J. Langley, N. C. Mishra, and M. L. Sopori. 2006. Early postnatal exposure to cigarette smoke impairs the antigen-specific T-cell responses in the spleen. Toxicol. Lett. 167: 231-237.
13. Mishra, N. C., J. Rir-Sima-ah, R. J. Langley, S. P. Singh, J. C. Peña-Philippides, T. Koga, S. Razani-Boroujerdi, J. Hutt, M. Campen, K. C. Kim, et al. 2008. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J. Immunol. 180: 7655-7663.
14. Warren, C. P. 1977. Extrinsic allergic alveolitis: a disease commoner in nonsmokers. Thorax 32: 567-569. (Pubitemid 8205842)
15. Calkins, B. M. 1989. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 34: 1841-1854.
16. Baron, J. A. 1996. Beneficial effects of nicotine and cigarette smoking: the real, the possible, and the spurious. Br. Med. Bull. 52: 58-73.
17. Netscher, D. T., and J. Clamon. 1994. Smoking: adverse effects on outcome for plastic surgical patients. Plast. Surg. Nurs. 14: 205-210.
18. Eskenazi, B., and M. L. Warner. 1997. Epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 24: 235-258.
19. Baldacci, S., P. Modena, L. Carrozi, M. Pedreschi, M. Vellutini, P. Biavati, M. Simoni, T. Sapigni, G. Viegi, P. Paoletti, and C. Giuntini. 1996. Skin prick test reactivity to common aeroallergens in relation to total IgE, respiratory symptoms, and smoking in a general population sample of northern Italy. Allergy 51: 149-156.
20. Troisi, R. J., F. E. Speizer, B. Rosner, D. Trichopoulos, and W. C. Willett. 1995. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest 108: 1557-1561.
21. Kalra, R., S. P. Singh, J. C. Peña-Philippides, R. J. Langley, S. Razani-Boroujerdi, and M. L. Sopori. 2004. Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clin. Diagn. Lab. Immunol. 11: 563-568.
22. Razani-Boroujerdi, S., S. P. Singh, C. Knall, F. F. Hahn, J. C. Peña-Philippides, R. Kalra, R. J. Langley, and M. L. Sopori. 2004. Chronic nicotine inhibits inflammation and promotes influenza infection. Cell. Immunol. 230: 1-9.
23. Wang, H., M. Yu, M. Ochani, C. A. Amella, M. Tanovic, S. Susarla, J. H. Li, H. Wang, H. Yang, L. Ulloa, et al. 2003. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
24. Saeed, R. W., S. Varma, T. Peng-Nemeroff, B. Sherry, D. Balakhaneh, J. Huston, K. J. Tracey, Y. Al-Abed, and C. N. Metz. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201: 1113-1123.
25. Thomson, N. C., R. Chaudhari, and E. Livingston. 2004. Asthma and cigarette smoking. Eur. Respir. J. 24: 822-833.
26. Singh, S. P., E. G. Barrett, R. Kalra, S. Razani-Boroujerdi, R. J. Langley, V. Kurup, Y. Tesfaigzi, and M. L. Sopori. 2003. Prenatal cigarette smoke decreases lung cAMP and increases airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 168: 342-347.
27. Kurup, V. P., S. Mauze, H. Choi, B. W. Seymour, and R. L. Coffman. 1992. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 148: 3783-3788.
28. Barrett, E. G., J. Wilder, T. H. March, T. Espindola, and D. E. Bice. 2002. Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am. J. Respir. Crit. Care Med. 165: 1410-1418.
29. Kurup, V. P. 2005. Aspergillus antigens: which are important? Med. Mycol. 43(Suppl. 1): S189-S196.
30. Brummund, W., A. Resnick, J. N. Fink, and V. P. Kurup. 1987. Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J. Clin. Microbiol. 25: 5-9.
31. Levallet, G., J. Levallet, H. Bouraima-Lelong, and P. J. Bonnamy. 2007. Expression of cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated activities in immature rat sertoli cells. Biol. Reprod. 76: 794-803.
32. Weitzman, M., S. Gortmaker, and A. Sobol. 1990. Racial, social, and environmental risks for childhood asthma. Am. J. Dis. Child. 144: 1189-1194. (Pubitemid 20360617)
33. Lundblad, L. K., C. G. Irvin, A. Adler, and J. H. Bates. 2002. A reevaluation of the validity of unrestrained plethysmography in mice. J. Appl. Physiol. 93: 1198-1207.
34. Hauk, P. J., M. Krawiec, J. Murphy, J. Boguniewicz, A. Schiltz, E. Goleva, A. H. Liu, and D. Y. Leung. 2008. Neutrophilic airway inflammation and association with bacterial lipopolysaccharide in children with asthma and wheezing. Pediatr. Pulmonol. 43: 916-923.
35. Jones, C. A., and P. G. Holt. 2000. Immunopathology of allergy and asthma in childhood. Am. J. Respir. Crit. Care Med. 162: S36-S39.
36. Poulsen, L. K., and L. Hummelshoj. 2007. Triggers of IgE class switching and allergy development. Ann. Med. 39: 440-456.
37. Kurup, V. P., and G. Grunig. 2002. Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia 153: 165-177.
38. Gosens, R., J. Zaagsma, H. Meurs, and A. J. Halayko. 2006. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 7: 73-88.
39. Struckmann, N., S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger. 2003. Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol. Pharmacol. 64: 1444-1451.
40. Floreani, A. A., and S. I. Rennard. 1999. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr. Opin. Pulm. Med. 5: 38-46.
41. Seymour, B. W., J. L. Peake, K. E. Pinkerton, V. P. Kurup, and L. J. Gershwin. 2005. Second-hand smoke increases nitric oxide and alters the IgE response in a murine model of allergic aspergillosis. Clin. Dev. Immunol. 12: 113-124.
42. Finch, G. L., K. J. Nikula, B. T. Chen, E. B. Barr, I. Y. Chang, and C. H. Hobbs. 1995. Effect of chronic cigarette smoke exposure on lung clearance of tracer particles inhaled by rats. Fundam. Appl. Toxicol. 24: 76-85.
43. Giembycz, M. A. 2008. Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking? Br. J. Pharmacol. 155: 288-290.
44. Spina, D. 2008. PDE4 inhibitors: current status. Br. J. Pharmacol. 155: 308-315.
45. Grootendorst, D. C., S. A. Gauw, N. Benschop, P. J. Sterk, P. S. Hiemstra, and K. F. Rabe. 2003. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19- 8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). Pulm. Pharmacol. Ther. 16: 341-347.
46. Field, S. K. 2008. Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma. Expert Opin. Investig. Drugs 17: 811-818.
47. Hansen, G., S. Jin, D. T. Umetsu, and M. Conti. 2000. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc. Natl. Acad. Sci. USA 97: 6751-6756.
48. Deng, Y. M., Q. M. Xie, H. F. Tang, J. G. Sun, J. F. Deng, J. Q. Chen, and S. Y. Yang. 2006. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Eur. J. Pharmacol. 547: 125-135.
49. Wollin, L., D. S. Bundschuh, A. Wohlsen, D. Marx, and R. Beume. 2006. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulm. Pharmacol. Ther. 19: 343-352.
50. Barnes, P. J., I. M. Adcock, and K. Ito. 2005. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 25: 552-563.
51. Adcock, I. M., K. Ito, and P. J. Barnes. 2005. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2: 445-455.
52. Lynch, M. J., G. S. Baillie, and M. D. Houslay. 2007. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique nonredundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling. Biochem. Soc. Trans. 35: 938-941.
53. Houslay, M. D., P. Schafer, and K. Y. Zhang. 2005. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov. Today 10: 1503-1519.
54. Mehats, C., S.-L. C. Jin, J. Wahlstrom, E. Law, D. L. Umetsu, and M. Conti. 2003. PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J. 17: 1831-1841.
55. Caulfield, M. P., and N. J. M. Birdsall. 1998. International Union of Pharmacology. XVII. Classification of muscaranic acetylcholine receptors. Pharmacol. Rev. 50: 279-290.
56. Hislop, A. A., J. C. Mak, J. A. Reader, P. J. Barnes, and S. G. Haworth. 1998. Muscaranic receptor subtype in the porcine lung during postnatal development. Eur. J. Pharmacol. 359: 211-221.
57. Nagai, T., D. J. Kim, R. J. Delay, and S. D. Roper. 1996. Neuromodulation of transduction and signal processing in the end organs of taste. Chem. Senses 21: 353-365.
58. Kishimoto, T. 2006. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res. Ther. 8(Suppl. 2): S2.
59. Foster, P. S., H. F. Rosenberg, K. L. Asquith, and R. K. Kumar. 2008. Targeting eosinophils in asthma. Curr. Mol. Med. 8: 585-590.
60. Conroy, D. M., and T. J. Williams. 2001. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir. Res. 2: 150-156.
61. Van der Maarel, S. M. 2008. Epigenetic mechanisms in health and disease. Ann. Rheum. Dis. 67(Suppl. 3): iii97-100.